Figure 1 (Terlivaz 01)
The text provides instructions for administering TERLIVAZ with an initial dose of 0.85 me (1 vial) every 6 hours. A baseline serum creatinine should be recorded on Day 1, and subsequent serum creatinine levels assessed on Day 4. If serum creatinine has decreased by 30% or more from baseline, continue TERLIVAZ at the same dose. If serum creatinine has decreased by less than 30% from baseline or is at or above baseline value, either increase the dose or discontinue treatment. TERLIVAZ should be continued until serum creatinine levels have been below 1.5 mg/dL for at least 24 hours or for a maximum of 14 days.*